Caribbean small states | Immunization, measles (% of children ages 12-23 months)

Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Caribbean small states
Records
63
Source
Caribbean small states | Immunization, measles (% of children ages 12-23 months)
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980 1.97672686
1981 5.34235765
1982 23.548075
1983 26.50521041
1984 50.80266649
1985 56.07931363
1986 50.27519658
1987 65.75597855
1988 69.77217566
1989 71.43942795
1990 74.9754735
1991 83.03562051
1992 72.03785284
1993 83.50775051
1994 83.66345557
1995 87.00982192
1996 92.55681098
1997 87.25317529
1998 89.44159069
1999 85.17347726
2000 88.93042162
2001 88.68051847
2002 87.69612575
2003 83.78782474
2004 89.4218312
2005 89.19575071
2006 89.08328552
2007 85.87029309
2008 90.89992838
2009 92.41357418
2010 91.49767243
2011 90.71576655
2012 89.8514738
2013 93.14396733
2014 92.17205851
2015 91.37599089
2016 91.78841957
2017 92.23081496
2018 89.82510722
2019 92.08360511
2020 86.86902131
2021 85.07572297
2022 88.15613926

Caribbean small states | Immunization, measles (% of children ages 12-23 months)

Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Caribbean small states
Records
63
Source